The health ministry confirmed 1,602 recoveries on Tuesday, bringing the total to 22,946 recovered patients
The Ministry of Health documented almost 8,000 domestic COVID-19 cases in Vietnam on Tuesday, with more than 6,000 recorded in Ho Chi Minh City.
Thirty-eight provinces and cities registered 7,911 locally-infected patients while two separate infections were imported from abroad, the health ministry said.
One thousand and sixty-three cases were detected in the community whereas the remainder were found in isolated areas or centralized quarantine facilities.
Ho Chi Minh City reported 6,318 of the latest domestic infections, Dong Thap Province 303, Dong Nai Province 239, Binh Duong Province 166, and Tay Ninh Province 144.
The daily count is the second-largest so far, after a record was set at 9,225 patients on Saturday.
Since the fourth COVID-19 wave began in Vietnam on April 27, the country has logged 110,487 community transmissions in 62 out of its 63 provinces and cities.
Ho Chi Minh City stays on top with 72,740 patients, followed by Binh Duong Province with 8,909, Bac Giang Province with 5,735, Long An Province with 3,931, Dong Nai Province with 2,714, Dong Thap Province with 2,397, and Tien Giang Province with 1,825.
By comparison, Vietnam confirmed 106 community cases in the first wave from January 23 to April 16, 2020, 554 in the second from July 25 to December 1, 2020, and 910 in the third from January 28 to March 25, 2021.
The health ministry confirmed 1,602 recoveries on Tuesday, bringing the total to 22,946 recovered patients. The death toll remains at 524.
The Southeast Asian nation has overall announced 112,057 domestic and 2,203 imported cases since the COVID-19 pandemic first hit it on January 23, 2020.
Health workers gave 109,234 vaccine doses today.
More than 4.7 million jabs have been administered to medical workers, teachers, factory workers, and other frontline staff since Vietnam rolled out inoculation on March 8.
About 423,000 people have been fully vaccinated.
The Vietnamese government expects to obtain 175 million shots of various vaccines, including 51 million Pfizer-BioNTech jabs, by early 2022.
It set a target of immunizing two-thirds of a population of nearly 98 million people against COVID-19 by the first quarter of next year.
